Evidence-Based Medicine Guidelines
Rivastigmine for Alzheimer’s disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rivastigmine for Alzheimer’s Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456417/all/_________Rivastigmine_for_Alzheimer’s_disease______.
Rivastigmine for Alzheimer’s disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/456417/all/_________Rivastigmine_for_Alzheimer’s_disease______. Accessed November 6, 2024.
Rivastigmine for Alzheimer’s disease. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456417/all/_________Rivastigmine_for_Alzheimer’s_disease______
Rivastigmine for Alzheimer’s Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456417/all/_________Rivastigmine_for_Alzheimer’s_disease______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rivastigmine for Alzheimer’s disease
ID - 456417
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456417/all/_________Rivastigmine_for_Alzheimer’s_disease______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
